Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Reviews in Endocrine and Metabolic Disorders

Issue 2/2009

Special Issue on: Therapeutic Challenges in Pituitary Diseases, Guest Editors: Leo Hofland and S. W. J. Lamberts

Content (8 Articles)

Somatostatin–dopamine ligands in the treatment of pituitary adenomas

Alexandru Saveanu, Philippe Jaquet

Open Access

Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome

C. de Bruin, R. A. Feelders, S. W. J. Lamberts, L. J. Hofland

Open Access

Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas

Marta Labeur, Marcelo Paez-Pereda, Eduardo Arzt, Günter K. Stalla

Medical therapy of pituitary adenomas: Effects on tumor shrinkage

Annamaria Colao, Rosario Pivonello, Carolina Di Somma, Silvia Savastano, Ludovica F. S. Grasso, Gaetano Lombardi

Potential role of type I interferons in the treatment of pituitary adenomas

Giovanni Vitale, Michele Caraglia, Peter M. van Koetsveld, Paola Maroni, Monica Marra, Annamaria Colao, Steven W. J. Lamberts, Francesco Cavagnini, Leo J. Hofland

Modern techniques for pituitary radiotherapy

G. Minniti, D. C. Gilbert, M. Brada

Growth hormone receptor modulators

Vita Birzniece, Akira Sata, Ken KY Ho

Advantages and disadvantages of GH/IGF-I combination treatment

J. A. M. J. L. Janssen

Mar 09
Issue: 1/2009
Special Issue on: Adrenarche, Guest Editors: Sharon E. Oberfield and Perrin C. White
Sep 09
Issue: 3/2009
Special Issue on Treatment for Childhood Obesity, Guest Editor: Brandon Nathan

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits